Soluble Biomarkers

Customised biomarker panels to enhance all stages of therapeutic development.

Innovative Biomarker Solutions for Clinical Research

Synexa Life Sciences has over two decades experience designing biomarker strategies to support customers’ broader clinical development objectives. Our team of scientists are experts in finding the optimum analytical strategy for biomarker selection, analysis and data interpretation.

Synexa’s global setup aims to support research programs from translational research through to late-stage clinical trials and post-marketing surveillance. Working collaboratively, we focus on careful selection of markers to ensure results that support decision-making and a significant return on investment.

Our Specialised Biomarker Services Include:

Advice on the optimal selection of biomarker in the context of the drug, disease and budget
Development, optimisation and validation of biomarker assays across a wide range of matrices and technology platforms
Biomarker analysis of clinical samples for exploratory or clinical trial settings

Biomarker Solutions

Protein

AlphaLISA
CBA
DELFIA
ELISA & ELISpot
Fluorescence and luminescence-based assays
Gyrolab
MesoScale
Nephelometry
Olink
Radioimmunoassays

DNA

Digital PCR (dPCR)
Electrophoresis
Pharmacogenetics
Targeted Sequencing

RNA

Gene expression array
NanoString
RT-qPCR

Cell

Cell Culture Assays
Circulating Tumor Cells (CTC)
Flow Cytometry
Fluorescence Microscopy
Microbiology
Sorting

Tissue

Correlative Light and Electron Microscopy (CLEM)
Multiplex Immunofluorescence
Organotypic culture
Super Resolution Microscopy
Whole Tissue Analysis

Robust and Proven Platforms

Our technology platforms are robust, reliable and reputable in the clinical field and provide comprehensive and detailed data readouts for your application.